GlassScriptPhysician profile
Allison Joy Kaper
NPI 1497399901
$1,031.26
in general payments reported to CMS, 2019-2025
24 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.04 · 2022: $108 · 2023: $179 · 2024: $433 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $255.32 | 2024-2025 | Daxxify |
| Novo Nordisk INC | $119.80 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $79.12 | 2023-2025 | Dupixent |
| Genzyme Corporation | $61.60 | 2024-2025 | |
| Amgen INC. | $54.80 | 2022-2024 | Otezla |
| Incyte Corporation | $53.36 | 2023-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $44.00 | 2024-2025 | |
| Janssen Biotech, INC. | $39.06 | 2023 | Tremfya |
| Leo Pharma INC. | $36.55 | 2024-2025 | Adbry |
| Organogenesis INC. | $35.36 | 2024 | |
| Abbvie INC. | $34.13 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $32.88 | 2023-2024 | Sotyktu |
| Botanix Sb INC | $22.55 | 2025 | Sofdra |
| Kerecis Limited | $19.60 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pfizer INC. | $17.86 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.86 | 2023 | Ilumya |
| Mylan Specialty L.P. | $15.64 | 2022 | |
| Ucb, INC. | $15.58 | 2024 | Bimzelx |
| Lilly USA, LLC | $14.54 | 2024 | Taltz |
| Verrica Pharmaceuticals INC. | $14.31 | 2024 | Ycanth |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.62 | 2021 | |
| Daiichi Sankyo INC. | $12.90 | 2021 | |
| Medtronic, INC. | $11.55 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Kaper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.